Project proposals can be submitted between October 1, 2020 and December 31, 2020.
German Federal Ministry for Economic Cooperation and Development (BMZ) could support your company’s innovative projects and commercial investments in developing and emerging-market countries provided that they offer long-term benefits for the local population.
Projects typically cover a wide range of sectors and themes – from training local experts and piloting innovative technologies and demonstration units to protecting value chains and improving manufacturers’ environmental and social standards.
The company is responsible for covering at least half of the overall costs.
At every stage, the company will work with one of the two official partners commissioned by BMZ to implement the programme on its behalf: DEG – Deutsche Investitions- und Entwicklungsgesellschaft mbH and Deutsche Gesellschaft für Internationale Zusammenarbeit (GIZ) GmbH.
The companies could submit their project idea to DEG or GIZ by participating in one of the ideas competitions held four times a year.
Companies with project ideas that offer potential development benefits and do not simply constitute an investment in their actual core business.
Between EUR 100,000 and EUR 2 million of public funding on top of your company’s own contribution (≥ 50%)
Minimum annual turnover: EUR 800,000
Minimum number of employees: 8
At least two years of audited financial statements
Up to three years
The first dedicated COVID-19 hospital in Kasargod, Kerala, built by the Tata Group, was inaugurated on 9 September 2020 by Chief Minister Pinarayi Vijayan. Built by the Tata Group using prefabricated containers in just five months at a cost of Rs 60 crore, the 551 bed hospital has 36 ventilators for the patients.
“The Covid hospital constructed by the Tata group, which will take care of the people during the pandemic, is an excellent example of how Public-Private Partnership can be put to good use” Chief Minister Vijayan said.
The 80,000 sq ft-hospital has been built on five acres of land at Thekkil village in Kasaragod. The authority to decide the facilities and the appointments to the hospital is with the state government.
Kazakstan Public -Private Partnership Center is inviting to submit proposals for PFI project in hospital construction in Kazakhstan.
The goal of the project is to create in the city of Turkestan a modern multidisciplinary hospital consisting of a hospital, a replacement technology hospital for 630 beds, and a consultative and diagnostic building with a capacity of 500 visits per shift.
Location of the project: the Republic of Kazakhstan, Turkestan city.
Project implementation period: 2020 – 2028 (98 months), including: investment period 2020 – 2023 (35 months), post-investment period 2023 – 2028 (63 months).
Requested payments from the budget: reimbursement of capital expenditures (CAPEX), operating expenditures (OPEX), management fee (MF).
Potential private partners interested in the implementation of the planned PPP project can submit alternative proposals on the possibility of implementing the planned Project.
Contacts: Ministry of Health of the Republic of Kazakhstan
Tel .: +7172 74 38 86, +7172 74 35 04
Mr Uzalin firstname.lastname@example.org
Mrs Akimbetova email@example.com
The Bicol Medical Center (BMC) – Medical Arts Building and Upgrading of Health Services aims to decongest the main hospital’s out-patient department (OPD) patients and laboratory requests effectively enhancing the quality of services of BMC, providing better health outcomes and achieving equitable access to healthcare in Region 5. Further, it will create sustainable revenue sources leading to BMC’s reduced dependence on national subsidy for its operational needs.
The PDMF is a revolving fund that supports pre-feasibility studies, feasibility studies, and other necessary pre-investment activities to help develop bankable PPP projects, as well as assistance in the PPP bidding process and for effective monitoring of PPP project implementation. Under the administration and management of the PPP Center, the PDMF provides government agencies with the required expertise and strategies to prepare well-structured projects that are selected to be undertaken as PPPs. The Facility is available for all national government agencies, government corporations, local implementing entities and state universities and colleges (SUCs), throughout the country. On the other hand, the PDMF Committee is the approving body for project support applications to the PDMF.
The pre-selection of four candidates has been completed on 31.07.2020 by Special Secretariat for Public –
Private Partnerships (PPPs) of the Greek Ministry of Economy and Development for the PPP project “Precision Medicine Infrastructure Project of the Biomedical Research Foundation of the Academy of Athens”. PPP project is supported by EBRD. A phase is completed with the prequalification of 4 candidates:
1. GEK TERNA S.A.
2. AKTOR CONCESSIONS S.A.
3. AVAX S.A.
4. INTRAKAT CONSTRUCTION S.A.
Source of information: Special Secretariat for Public –
Private Partnerships (PPPs), Greek Ministry of Economy and Development.
This is the first time that the Bank is supporting a PPP project in Greece. The venture includes the construction, acquisition of equipment and facility management of a new building for the provision of specialised services in the field of personalised medicine. The new facilities will house a state-of-the-art laboratory that meets high-tech specifications, in area totalling 20,000 m².
Furthermore, the project includes the renovation of the Loverdeion building, in order to create a unit for clinical trials of generic drugs. The total investment is estimated to be approximately €52 million.
The EBRD will cover the costs of technical assistance in the organisation of this PPP project as well as the cost of preparing fair and transparent tenders in order to attract the participation of private investors.
The BRFAA is a non-profit institute dedicated to understanding, treating and preventing human diseases, such as diabetes, cancer, Alzheimer’s and cardiomyopathies, through biomedical research. Established by the Academy of Athens, the foundation provides state-of-the-art facilities for conducting internationally competitive biomedical research and works with more than 250 postdoctoral fellows, laboratory technicians and PhD students.
The Ministry of Health of the Republic of Uzbekistan, with the assistance of the Public-Private Partnerships (PPP) Development Agency under the Ministry of Finance, on 19th of August, 2020 approved the tender documentation for the PPP Project for Dialysis services in Uzbekistan and invited the pre-qualified companies to submit their technical and financial proposals for the project.
It is planned to attract an international operator for the construction, financing and equipment of modern dialysis clinics in the city of Tashkent, the Republic of Karakalpakistan and the Khorezm region and for the provision of dialysis services in accordance with international quality standards for patients with chronic renal failure. The project will also introduce a new peritoneal dialysis technology that will allow patients to be more mobile and receive dialysis treatment while continuing to work and study.
Currently, four international companies are participating in the tender, which are some of the largest global dialysis companies and have many clinics in countries around the world. The completion of the tender and the signing of the agreement is expected by the end of the calendar year. The project was initiated by the Ministry of Health, the Ministry of Finance and the PPP Development Agency as part of the health sector reform to improve the quality of dialysis, to improve patient survival rates, to implement new technologies and training, and to attract foreign investment to the health sector in Uzbekistan.
The International Finance Corporation (IFC), a member of the World Bank Group, is the lead transactional advisor to the Ministry of Health and the Ministry of Finance for the Project.
Today we are talking to Prof. Veronica Vecchi,
member of PPPHealth4All. Veronica is Professor at
Bocconi University School of Management (Sda Bocconi)
- 3rd top business school in Europe according to the
FT ranking, where Veronica teaches Business
Government Relations and is director of the Executive
MBA at Sda Bocconi India Center, the off shore campus
of Bocconi in Mumbai. She has published numerous
publications and articles on PPPs in the healthcare
What is in your view the specifics of healthcare PPPs compared to other PPPs?
We can approach public private partnerships in two ways. PPP have been used so far mainly to design, finance, build and operate large hospitals in many countries with contested results, especially because of a lack of affordability due to weak financial, project management, and strategic skills in the public sector and the choice to include many non-core services in the transaction. The latter resulted in quite large contracts with a limited risks transfer, which, instead, is the essential feature of a PPP project. In the last 15 years I’ve been involved in structuring and renegotiating many PPP projects in Italy and I’ve worked closely with many scholars within the academic 3P network; this has allowed me to combine theory with practice and to develop a new approach to PPP in health, which I called PPP light, whose features are well described in my recent paper (PPP in Health Care—Trending Toward a Light Model: Evidence From Italy, published by Public Works management and policy).
The essence of the light model is the fact that a PPP contract in health must be designed by looking at the main goal to be achieved, thus avoiding to include peripherals that may increase the contract complexity and information asymmetry, which can undermine a correct risk allocation, because of the ramified web of subcontracts. Therefore, when the need is to build a new hospital, my suggestion is to include in the contract only essential activities such as design, building, maintenance and energy management, which are services strictly related to the need of a new/renewed hospital building. A PPP light can be applied also to the installment and operation of medical equipment or to small parts of hospitals, such as high intensity care units.
From a second and wider perspective, public – private collaborations can be seen also in the medical device field, with the development of value based contracts, or for the delivery of innovative services, based on digital transformation and internet of things. When PPP is applied to services, rather than cement, there is a greater opportunity to link the payment to the economic operator to the achievement of certain results, not only in terms of efficiency but also in terms of effectiveness.
What are the lessons learnt and impact on COVID-19 for healthcare PPPs?
In my perspective we need a twist in the way in which PPP is used in health. One of the lessons we can take from Covid-19 pandemic is the opportunity to move healthcare procurement towards a more strategic approach, where public-private collaboration can play a significant role to develop more resilient healthcare systems. Indeed, during the emergency, “hastily-generated” partnerships have bloomed. They are not only fundamental to ensure resilience in outbreaks; they can also pave the way for the creation of collaboration and trust to move public procurement towards a more strategic approach and to develop partnerships on a larger scale. Policy-makers should reflect on which areas of procurement would be less affected during the outbreak if previous partnerships existed with market suppliers, by comparing flexibility, rapidity and business continuity offered by contractual agreements based on different levels of collaboration. This issue has been developed in a paper published by the American Review of Public Administration (Medical Supply Acquisition in Italy and the United States in the Era of COVID-19: The Case for Strategic Procurement and Public–Private Partnerships) and in a short note published by the World Economic Forum.
What has to be done to improve PPPs in the healthcare sector?
To get the most from public-private collaborations we need not only new management competence to move procurement from a compliance-based perspective into a risk-management perspective, but also a new strategic approach to procurement – when the public sector behaves as a sophisticated buyer and where procurement is used also to achieve policy goals, such as business resilience, innovation and the creation of national/European production.
A new set of skills is required not only in the public sector but also in the private sector, to generate a common playing field fundamental to develop trust and therefore to co-create more sustainable, balanced and innovative partnerships. In this landscape, I think that women could play a salient role, therefore it is welcome any attempt to develop networks of women who can contribute to the development of this renewed approach to PPPs in health.
What could be your added-value to PPPHealth4All ecosystem?
I believe that the role of women is crucial for more sustainability
in healthcare procurement and PPP and wish to contribute to the
establishment of an international women network in this field to
exchange experiences and disseminate good practices. With reference to the latter, best practices should be applied with great attention to the contexts’ specifics to avoid mistakes already done, especially when many countries imported the anglosaxon PPP model.
Thanks a lot! We wishing you a lot of success in your work! Interview by Natalia Korchakova-Heeb, founder of PPPHealth4All
The list of articles published by
Prof. Veronica Vecchi:
Vecchi V., Hellowell (2018), Public Private Partnership in the healthcare sector, Palgrave Pivot
Colla P., Hellowell M., Vecchi V., Gatti S., (2015), Determinants
of the price of equity in hospital private finance initiative projects,
Hellowell, M., & Vecchi, V. (2015). The Non-Incremental Road to Disaster? A Comparative Policy Analysis of Agency Problems in the Commissioning of Infrastructure Projects in the UK and Italy Journal of Comparative Policy Analysis: Research and Practice, 1-14
Vecchi V., Hellowell M., Gatti S., (2013), Does the private sector
receive an excessive rate of return from investments in health care
infrastructure? Evidence from the UK. Health Policy, 110 (2-3): 243 –
Hellowell M., Vecchi V., (2013), Better deal from investors in public
infrastructure projects: insights from capital budgeting. Public
Management Review, 15(1): 109-129
„It is my pleasure to join the advisory board of PPPHealth4All. Our different backgrounds, knowledge and experience in the AB will strengthen its value and contribution. Having been through a two-years journey of two healthcare PPPs in the Kingdom of Saudi Arabia for a total value over $1 bln, I know the desperate needs for guiding and helpful resources in such endeavours. We studied other countries’ experiences, attended seminars, reviewed literature and consulted experts in the field. We always hoped that there was an independent body who could give us help. I hope PPPhealth4all will be able to play an important role in that regard. The spectrum of PPP outcome throughout the world in different sectors varies significantly. Governments had moved back and forth in their desire and ambition towards PPP. Standardizing the basic steps all parties will take in any country to succeed in the project is developing with different models and significant variation”- says Dr. Tariq Linjawi.
Main motivation to join PPPHealth4All for the Faculty of Law of the University of Niš is to support Serbian researchers interested in topics around healthcare PPPs and to gain substantial knowledge in this regard in order to develop it further in academic discourse and to finally apply it in practice.
Faculty of Law of the University of Niš is interested in development and drafting of regulatory documents in the form of soft law, such as:
-model laws dealing with PPP in healthcare sector;
– guidelines for contract drafting;
-model agreements for different types and objects of PPP in healthcare sectors (hospitals, rehabilitation facilites, PPP in primary, secondary and tertiary healthcare)
-creating and implementing training programmes for interested parties
Serbia is on the way to explore healthcare PPPs and has already developed the following legislation in this regard:
1. LAW ON PUBLIC-PRIVATE PARTNERSHIP AND CONCESSIONS
(“Off. Herald of RS”, Nos. 88/2011, 15/2016 and 104/2016)
2. LAW ON PUBLIC PROCUREMENT
(“Off. Herald of RS”, Nos. 124/2012, 14/2015 and 68/2015)
3. LAW ON INVESTMENTS
(“Off. Herald of RS”, Nos. 89/2015 and 95/2018)
4. Law o Healthcare Regulation (“Off. Herald of Rs”, Nos. 25/2019)
5. Law on Health Insurance (“Off. Herald of Rs”, Nos. 25/2019)
We wishing the Faculty of Law, the University of Niš a fruitful cooperation with members of the PPPHealth4All ecosystem and hope that this would result in a pipeline of healthcare PPP projects in Serbia.